Literature DB >> 4186803

Clinical aspects of IgE myeloma.

M Ogawa, S Kochwa, C Smith, K Ishizaka, O R McIntyre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4186803     DOI: 10.1056/NEJM196911272812204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Survival of twenty-two months in a patient with primary plasma cell leukaemia treated with melphalan and prednisolone.

Authors:  J D Walker; R S Kaczmarski
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

2.  [Immunoglobulin E. Biochemical, immunological properties and clinical significance (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1974-01-01

Review 3.  Current concepts of the pathogenesis and management of asthma.

Authors:  M H Grieco
Journal:  Bull N Y Acad Med       Date:  1970-08

4.  IgE in immunodeficiency.

Authors:  S H Polmar; T A Waldmann; W D Terry
Journal:  Am J Pathol       Date:  1972-12       Impact factor: 4.307

5.  Immunohistochemical localization of IgE in asthmatic lungs.

Authors:  M A Gerber; F Paronetto; S Kochwa
Journal:  Am J Pathol       Date:  1971-03       Impact factor: 4.307

6.  Concanavalin A induced histamine release from human basophils in vitro.

Authors:  A M Magro; H Bennich
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

7.  Hyperviscosity syndrome in IgE myeloma.

Authors:  N West
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-01

8.  Atopy as a minimal immunodeficiency?

Authors:  G R Burgio; L Nespoli; A G Ugazio
Journal:  Eur J Pediatr       Date:  1978-12-01       Impact factor: 3.183

9.  Naturally occurring human antiglobulins with specificity for E.

Authors:  R C Williams; R W Griffiths; J D Emmons; R C Field
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

10.  IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy.

Authors:  L M Lichtenstein; K Ishizaka; P S Norman; A K Sobotka; B M Hill
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.